![](/img/cover-not-exists.png)
Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint
Lacy, Brian E., Nicandro, Jean Paul, Chuang, Emil, Earnest, David L.Volume:
11
Language:
english
Journal:
Therapeutic Advances in Gastroenterology
DOI:
10.1177/1756284818771674
Date:
January, 2018
File:
PDF, 412 KB
english, 2018